Physician profile
Norma Waite
NPI 1679518096
$746.65
in general payments reported to CMS, 2019-2025
13 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $71.99 · 2021: $114 · 2022: $50.59 · 2023: $14.53 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $165.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $147.33 | 2019-2022 | |
| Medical Device Business Services, INC. | $129.48 | 2025 | Vistaseal |
| Exeltis, USA INC. | $97.26 | 2019-2021 | |
| Smith+Nephew, INC. | $87.58 | 2019 | |
| Abbvie INC. | $70.67 | 2020-2021 | |
| Allergan, INC. | $61.17 | 2019-2020 | |
| Hologic Sales and Service, LLC | $52.64 | 2019-2021 | |
| Mission Pharmacal Company | $23.36 | 2019-2020 | |
| Organon LLC | $21.82 | 2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $14.53 | 2023 | Myfembree |
| Agile Therapeutics, INC. | $13.89 | 2022 | |
| Avion Pharmaceuticals | $13.82 | 2019 | |
| Scynexis, INC. | $13.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norma Waite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.